Abstract
The farnesoid X receptor (FXR) is a nuclear receptor responsible for homeostasis of bile acids, lipids, and glucose. Compounds that alter endogenous FXR signaling can be used as therapeutic candidates or identified as potentially hazardous compounds depending on exposure doses and health states. Therefore, there is an increasing need for high-throughput screening assays of FXR activity to profile large numbers of environmental chemicals and drugs. This chapter describes a workflow of FXR modulator identification and characterization. To identify compounds that modulate FXR transactivation at the cellular level, we first screen compounds from the Tox21 10 K compound library in an FXR-driven beta-lactamase reporter gene assay multiplexed with a cell viability assay in the same well of the 1536-well plates. The selected compounds are then tested biochemically for their ability to modulate FXR-coactivator binding interactions using a time-resolved fluorescence resonance energy transfer (TR-FRET) coactivator assay. The assay results from the workflow can be used to prioritize compounds for more extensive investigations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kuipers F, Bloks VW, Groen AK (2014) Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 10(8):488–498. doi:10.1038/nrendo.2014.60
Merk D, Steinhilber D, Schubert-Zsilavecz M (2012) Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators. Future Med Chem 4(8):1015–1036. doi:10.4155/fmc.12.47
Lamers C, Schubert-Zsilavecz M, Merk D (2014) Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists. Curr Top Med Chem 14(19):2188–2205
Zheng ZH, Lv GP, Si SY, Dong YS, Zhao BH, Zhang H, He JG (2007) A cell-based high-throughput screening assay for Farnesoid X receptor agonists. Biomed Environ Sci 20(6):465–469
Wu X, Glickman JF, Bowen BR, Sills MA (2003) Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists. J Biomol Screen 8(4):381–392. doi:10.1177/1087057103256466
Hsu CW, Zhao J, Huang R, Hsieh JH, Hamm J, Chang X, Houck K, Xia M (2014) Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Sci Rep 4:6437. doi:10.1038/srep06437
Han KC, Kim JH, Kim KH, Kim EE, Seo JH, Yang EG (2010) Identification of farnesoid X receptor modulators by a fluorescence polarization-based interaction assay. Anal Biochem 398(2):185–190. doi:10.1016/j.ab.2009.11.008
Yu DD, Lin W, Chen T, Forman BM (2013) Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery. Bioorg Med Chem 21(14):4266–4278. doi:10.1016/j.bmc.2013.04.069
Glickman JF, Wu X, Mercuri R, Illy C, Bowen BR, He Y, Sills M (2002) A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors. J Biomol Screen 7(1):3–10. doi:10.1089/108705702753520288
Fujino T, Sato Y, Une M, Kanayasu-Toyoda T, Yamaguchi T, Shudo K, Inoue K, Nishimaki-Mogami T (2003) In vitro farnesoid X receptor ligand sensor assay using surface plasmon resonance and based on ligand-induced coactivator association. J Steroid Biochem Mol Biol 87(4-5):247–252
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hsu, CW.(., Zhao, J., Xia, M. (2016). Transactivation and Coactivator Recruitment Assays for Measuring Farnesoid X Receptor Activity. In: Zhu, H., Xia, M. (eds) High-Throughput Screening Assays in Toxicology. Methods in Molecular Biology, vol 1473. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6346-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6346-1_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6344-7
Online ISBN: 978-1-4939-6346-1
eBook Packages: Springer Protocols